Curcumin and Neurocognitive Health: Mechanistic Insights and Translational Clinical Evidence

  • Authors

    • Suhas S Department of Nutrition and Dietetics, JSS Academy of Higher Education and Research, ‎ Mysuru, India
    • Preethi R Department of Food Science and Nutrition, Bharathi College, Mandya, India
    • Vanitha Reddy P Department of Nutrition and Dietetics, JSS Academy of Higher Education and Research, ‎ Mysuru, India
    https://doi.org/10.14419/06fd2p85

    Received date: February 19, 2026

    Accepted date: April 8, 2026

    Published date: April 15, 2026

  • Curcumin; Neurocognition; Neuroinflammation; Polyphenols

  • Abstract

    Neurocognitive decline represents a growing public health concern, with limited disease-‎modifying therapeutic options currently available. Curcumin, a polyphenolic compound derived ‎from Curcuma longa, has attracted interest due to its proposed neuroprotective properties, ‎however, translating experimental findings into consistent clinical benefits remains uncertain. ‎This narrative review synthesises mechanistic, preclinical, and clinical evidence examining the ‎role of curcumin in neurocognitive health and highlights key translational challenges. ‎Experimental studies demonstrate modulation of oxidative stress, neuroinflammatory signalling, ‎amyloid aggregation, and neurotrophic pathways, supporting biological plausibility. Preclinical ‎models frequently report improvements in learning and memory, though effects often occur at ‎exposure levels not readily achievable in humans. Clinical evidence remains heterogeneous and ‎influenced by formulation, bioavailability, dosage, intervention duration, and cognitive ‎assessment methods. Conventional curcumin preparations generally show limited cognitive ‎benefit, whereas selected trials using enhanced-bioavailability formulations report modest ‎improvements, primarily in non-demented older adults. Curcumin supplementation is generally ‎well tolerated, although long-term safety data remain limited. Overall, despite compelling ‎mechanistic rationale, current clinical evidence is insufficient to support routine use of curcumin ‎for neurocognitive enhancement or treatment of neurodegenerative disease, underscoring the ‎need for rigorously designed trials using standardised formulations and robust cognitive and ‎biomarker-based outcomes‎.

  • References

    1. Prince M, Wimo A, Guerchet M, Ali GC, Wu YT, Prina M. The Global Impact of Dementia. London: Alzheimer’s Disease International; 2015.
    2. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet. 2020;396(10248):413–46. https://doi.org/10.1016/S0140-6736(20)30367-6.
    3. Cummings J, Lee G, Nahed P, Kambar MEZN, Zhong K, Fonseca J, Taghva K. Alzheimer’s disease drug development pipeline: 2022. Alzheimers Dement (N Y). 2022;8(1): e12295. https://doi.org/10.1002/trc2.12295.
    4. Heneka MT, Carson MJ, El Khoury J, et al. Neuroinflammation in Alzheimer’s disease. Lancet Neurol. 2015;14(4):388–405. https://doi.org/10.1016/S1474-4422(15)70016-5.
    5. Butterfield DA, Halliwell B. Oxidative stress, dysfunctional glucose metabolism and Alzheimer's disease. Nat Rev Neurosci. 2019;20(3):148–160. https://doi.org/10.1038/s41583-019-0132-6.
    6. Vauzour D, Rodriguez-Mateos A, Corona G, Oruna-Concha MJ, Spencer JPE. Polyphenols and human health: prevention of disease and mechanisms of action. Nutrients. 2010;2(11):1106–1131. https://doi.org/10.3390/nu2111106.
    7. Aggarwal BB, Harikumar KB. Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pul-monary, metabolic, autoimmune, and neoplastic diseases. Int J Biochem Cell Biol. 2009;41(1):40–59. https://doi.org/10.1016/j.biocel.2008.06.010.
    8. Cole GM, Teter B, Frautschy SA. Neuroprotective effects of curcumin. Adv Exp Med Biol. 2007; 595: 197–212. https://doi.org/10.1007/978-0-387-46401-5_8.
    9. Hewlings SJ, Kalman DS. Curcumin: a review of its effects on human health. Foods. 2017;6(10):92. https://doi.org/10.3390/foods6100092.
    10. Small GW, Siddarth P, Li Z, Miller KJ, Ercoli L, Emerson ND, et al. Memory and brain amyloid and tau effects of a bioavailable form of curcumin in non-demented adults: a double-blind, placebo-controlled 18-month trial. Am J Geriatr Psychiatry. 2018;26(3):266–277. https://doi.org/10.1016/j.jagp.2017.10.010.
    11. Rainey-Smith SR, Brown BM, Sohrabi HR, Shah T, Goozee KG, Gupta VB, Martins RN. Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults. Br J Nutr. 2016 Jun;115(12):2106-13. https://doi.org/10.1017/S0007114516001203.
    12. Ng TP, Chiam PC, Lee T, Chua HC, Lim L, Kua EH. Curry consumption and cognitive function in the elderly. Am J Epidemiol. 2006;164(9):898–906. https://doi.org/10.1093/aje/kwj267.
    13. Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin. J Med Chem. 2017;60(5):1620–1637. https://doi.org/10.1021/acs.jmedchem.6b00975.
    14. Ioannidis JPA. Why most clinical research is not useful. PLoS Med. 2016;13(6): e1002049. https://doi.org/10.1371/journal.pmed.1002049.
    15. Ferrari R. Writing narrative style literature reviews. Med Writ. 2015;24(4):230–235. https://doi.org/10.1179/2047480615Z.000000000329.
    16. Ma Q. Role of Nrf2 in oxidative stress and toxicity. Annu Rev Pharmacol Toxicol. 2013; 53:401–426. https://doi.org/10.1146/annurev-pharmtox-011112-140320.
    17. Shishodia S, Amin HM, Lai R, Aggarwal BB. Curcumin (diferuloylmethane) inhibits constitutive NF-kappaB activation, induces G1/S arrest, sup-presses proliferation, and induces apoptosis in mantle cell lymphoma. Biochem Pharmacol. 2005 Sep 1;70(5):700-13. https://doi.org/10.1016/j.bcp.2005.04.043.
    18. Ringman JM, Frautschy SA, Cole GM, Masterman DL, Cummings JL. A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alz-heimer Res. 2005 Apr;2(2):131-6. https://doi.org/10.2174/1567205053585882.
    19. Xu Y, Ku B, Cui L, Li X, Barish PA, Foster TC, Ogle WO. Curcumin reverses impaired hippocampal neurogenesis and increases serotonin receptor 1A mRNA and brain-derived neurotrophic factor expression in chronically stressed rats. Brain Res. 2007; 1162: 9-18. https://doi.org/10.1016/j.brainres.2007.05.071.
    20. Reuter S, Gupta SC, Park B, Goel A, Aggarwal BB. Epigenetic changes induced by curcumin and other natural compounds. Genes Nutr. 2011;6(2):93-108. https://doi.org/10.1007/s12263-011-0222-1.
    21. Cox KH, Pipingas A, Scholey AB. Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. J Psycho-pharmacol. 2015 May;29(5):642-51. https://doi.org/10.1177/0269881114552744.
    22. Wang W, Zhao R, Liu B, Li K. The effect of curcumin supplementation on cognitive function: an updated systematic review and meta-analysis. Front Nutr. 2025 Apr 16; 12: 1549509. https://doi.org/10.3389/fnut.2025.1549509.
    23. Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807–818. https://doi.org/10.1021/mp700113r.
    24. Begum AN, Jones MR, Lim GP, Morihara T, Kim P, Heath DD, et al. Curcumin structure–function, bioavailability, and efficacy in models of neuroin-flammation and Alzheimer’s disease. J Pharmacol Exp Ther. 2008;326(1):196–208. https://doi.org/10.1124/jpet.108.137455.
    25. Cuomo J, Appendino G, Dern AS, Schneider E, McKinnon TP, Brown MJ, et al. Comparative absorption of a standardized curcuminoid mixture and its lecithin formulation. J Nat Prod. 2011;74(4):664–669. https://doi.org/10.1021/np1007262.
    26. Prasad S, Tyagi AK, Aggarwal BB. Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice. Cancer Res Treat. 2014;46(1):2-18. https://doi.org/10.4143/crt.2014.46.1.2.
    27. Lopresti AL. The problem of curcumin and its bioavailability: could its gastrointestinal influence contribute to its overall health-enhancing effects? Adv Nutr. 2018;9(1):41–50. https://doi.org/10.1093/advances/nmx011.
    28. Di Meo F, Margarucci S, Galderisi U, Crispi S, Peluso G. Curcumin, gut microbiota, and neuroprotection. Nutrients. 2019;11(10):2426. https://doi.org/10.3390/nu11102426.
    29. Francis AJ, Sreenivasan C, Parikh A, AlQassab O, Kanthajan T, Pandey M, Nwosu M. Curcumin and Cognitive Function: A Systematic Review of the Effects of Curcumin on Adults with and Without Neurocognitive Disorders. Cureus. 2024 Aug 25;16(8):e67706. https://doi.org/10.7759/cureus.67706.
    30. Lao CD, Ruffin MT IV, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Al-tern Med. 2006; 6:10. https://doi.org/10.1186/1472-6882-6-10.
    31. Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4B):2895–2900.
    32. Chainani-Wu N. Safety and anti-inflammatory activity of curcumin: a component of turmeric (Curcuma longa). J Altern Complement Med. 2003;9(1):161–168. https://doi.org/10.1089/107555303321223035.
    33. Gupta SC, Patchva S, Aggarwal BB. Therapeutic roles of curcumin: lessons learned from clinical trials. AAPS J. 2013;15(1):195–218. https://doi.org/10.1208/s12248-012-9432-8.
    34. Hatcher H, Planalp R, Cho J, Torti FM, Torti SV. Curcumin: from ancient medicine to current clinical trials. Cell Mol Life Sci. 2008;65(11):1631–1652. https://doi.org/10.1007/s00018-008-7452-4.
    35. Soleimani V, Sahebkar A, Hosseinzadeh H. Turmeric (Curcuma longa) and its major constituent curcumin as nontoxic and safe substances: a review. Phytother Res. 2018;32(6):985–995. https://doi.org/10.1002/ptr.6054.
    36. Kunnumakkara AB, Bordoloi D, Padmavathi G, Monisha J, Roy NK, Prasad S, Aggarwal BB. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases. Br J Pharmacol. 2017;174(11):1325–48. https://doi.org/10.1111/bph.13621.

  • Downloads

  • How to Cite

    S, S., R, P., & P, V. R. (2026). Curcumin and Neurocognitive Health: Mechanistic Insights and Translational Clinical Evidence. International Journal of Biological Research, 13(1), 1-7. https://doi.org/10.14419/06fd2p85